NGL Fine-Chem (NSE:NGLFINE) PEG Ratio: N/A (As of Jul. 07, 2026)


NSE:NGLFINE NGL Fine-Chem Ltd NSE:NGLFINE
81 GF Score
Price ₹3,092.30
GF Value ₹2,820.12
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is NGL Fine-Chem PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, NGL Fine-Chem's PE Ratio without NRI is 39.76. NGL Fine-Chem's 5-Year EBITDA growth rate is -3.80%. Therefore, NGL Fine-Chem's PEG Ratio for today is N/A.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for NGL Fine-Chem's PEG Ratio or its related term are showing as below:


During the past 13 years, NGL Fine-Chem's highest PEG Ratio was 12.00. The lowest was 0.20. And the median was 0.97.


NSE:NGLFINE's PEG Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.7
* Ranked among companies with meaningful PEG Ratio only.

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


NGL Fine-Chem  (NSE:NGLFINE) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


NGL Fine-Chem PEG Ratio Related Terms


NGL Fine-Chem PEG Ratio Historical Data

* Premium members only.

The historical data trend for NGL Fine-Chem's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NGL Fine-Chem PEG Ratio Chart

NGL Fine-Chem Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
PEG Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.69 1.83 3.18 10.48 0.00

NGL Fine-Chem Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.48 0.00 0.00 0.00 0.00

NSE:NGLFINE vs LLY, JNJ, ABBV: PEG Ratio Comparison

For the Drug Manufacturers - General subindustry, NGL Fine-Chem's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NGL Fine-Chem PEG Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, NGL Fine-Chem's PEG Ratio distribution charts can be found below:

* The bar in red indicates where NGL Fine-Chem's PEG Ratio falls into.


NSE:NGLFINE
81GF Score
NGL Fine-Chem Ltd NSE:NGLFINE
PEG Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NGL Fine-Chem PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

NGL Fine-Chem's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=39.76211906905/-3.80
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.

Is NGL Fine-Chem (NSE:NGLFINE) Overvalued in 2026?

Based on GuruFocus' analysis, NGL Fine-Chem stock appears to be overvalued. The current stock price of ₹3,092.30 is trading 9.7% above its estimated GF Value™ of ₹2,820.12. GuruFocus considers NGL Fine-Chem to be Fairly Valued.

Key valuation signals for NSE:NGLFINE:

  • PEG Ratio: N/A
  • GF Value™: ₹2,820.12 vs. price of ₹3,092.30 (9.7% above fair value)
  • GF Score™: 81/100 with 8 warning signs

No single metric tells the full story. See the NSE:NGLFINE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


NGL Fine-Chem Business Description

Other Exchanges 524774:India
Address 301, E Square, Subhash Road, Vile Parle (East), Mumbai, MH, IND, 400057
NGL Fine-Chem Ltd is an Indian company engaged in the pharmaceutical business. It is a manufacturer of pharmaceuticals and intermediates for use in veterinary and human health, catering to various companies to custom-manufacture pharmaceuticals. The company's product portfolio comprises animal health APIs such as homidium chloride, nitroxynil, clorsulon, decoquinate, fenbendazole, etc.; human health APIs such as nitazoxanide and atovaquone; drug intermediates and specialty chemicals; and finished dosage forms such as diminazene aceturate granules and homidium chloride tablets. Geographically, the group generates maximum revenue from the Asia-Pacific region, and the rest from India, Europe, the USA, and the rest of the world.
81GF Score

Get the complete analysis for NSE:NGLFINE

PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹3,092.30
Price
₹2,820.12
GF Value